When the doctor gives us medicine, it is often in the shape of a pill.
But when it comes to brain diseases, pills are actually an extremely ineffecient way to deliver drugs to the brain, and according to researchers from University of Southern Denmark we need to find new and more efficient ways of transporting drugs to the brain. Spraying the patient’s nose could be one such way.
Read more . . .
The Latest on: Delivering drugs to the brain
via Google News
The Latest on: Delivering drugs to the brain
- Incannex Healthcare partners with R&D organisation Curia to scale-up manufacture of drug targeting traumatic brain injuryon August 1, 2022 at 5:22 pm
"Its manufacture will facilitate investigation of the product in the well-controlled clinical trials we are designing, with feedback ...
- Incannex Engages Curia to scale-up manufacture of inhaled drug product to treat traumatic brain injuryon August 1, 2022 at 7:10 am
Incannex (ASX:IHL) advances its inhaled drug product for treatment of traumatic brain injury, with a new development and manufacturing deal.
- The fight against Alzheimer's: Where are we now?on July 31, 2022 at 12:02 am
Decades of Alzheimer's research may not have given us a blockbuster drug, but it has shown that a combination of lifestyle changes and treatment may be the key to preventing and slowing the disease.
- Stroke drug improves memory and repairs injured brain tissue in miceon July 28, 2022 at 9:42 am
Unlike existing treatments that focus on rehabilitation or reducing the risk of an additional stroke, the experimental drug targets the "stickiness" that can prevent injured brain tissue from function ...
- New drugs and surgery can deliver major weight loss. But they come at a cost.on July 26, 2022 at 2:01 am
As the scientific understanding of weight loss deepens, new treatments are getting better but most are expensive and require a life-long commitment.
- Drug that could be the first and only in Europe to treat rare brain condition recommended for marketing authorizationon July 25, 2022 at 11:41 am
A drug to treat a rare condition characterized by brain dysfunction has been recommended for marketing authorization.
- Research reveals molecular clues associated with traumatic brain injuryon July 24, 2022 at 12:30 pm
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known ...
- Scientists find molecular clues behind acute and chronic phases of traumatic brain injuryon July 22, 2022 at 11:30 pm
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known ...
- New study finds pulsed MRI system could deliver drugs to the brainon July 20, 2022 at 5:00 pm
In results published today in the journal Pharmaceutics, Weinberg Medical Physics (WMP) has demonstrated the ability to open the blood-brain-barrier (BBB) in mice and to safely deliver drugs using ...
- Nanobiotechnology-Based Strategies for Crossing the Blood–Brain Barrieron June 8, 2022 at 5:00 pm
The blood–brain barrier (BBB) is a significant obstacle to therapeutic delivery for CNS disorders. Among various strategies, nanobiotechnology plays an important role in facilitating drug ...
via Bing News